Acquisitions - Canopy Biosciences (Details) - USD ($) $ in Millions				12 Months Ended
	Nov. 17, 2021	Sep. 10, 2020	Oct. 15, 2018	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Consideration Transferred:
Total consideration transferred	$ 14.4		$ 6.1	$ 4.5
Allocation of Consideration Transferred:
Operating lease assets				59.9	$ 67.4
Goodwill				339.5	$ 320.4	$ 293.0	$ 275.7
Canopy Biosciences
Business Acquisition [Line Items]
Purchase price		$ 24.2
Potential additional consideration		5.0
Consideration Transferred:
Cash paid		24.4
Contingent consideration		0.5
Cash acquired		(0.5)
Working capital adjustment		0.3
Total consideration transferred		24.7
Allocation of Consideration Transferred:
Accounts receivable		1.2
Inventories		1.1
Other current assets		1.0
Property, plant and equipment		0.9
Operating lease assets		0.3
Goodwill		12.0
Deferred taxes		(2.0)
Liabilities assumed		(2.6)
Total consideration transferred		$ 24.7
Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability				$ 0.5
Canopy Biosciences | Technology
Business Acquisition [Line Items]
Amortization period for intangible assets acquired		10 years
Allocation of Consideration Transferred:
Intangible assets		$ 5.7
Canopy Biosciences | Customer relationships
Business Acquisition [Line Items]
Amortization period for intangible assets acquired		10 years
Allocation of Consideration Transferred:
Intangible assets		$ 6.1
Canopy Biosciences | Trade name
Business Acquisition [Line Items]
Amortization period for intangible assets acquired		8 years
Allocation of Consideration Transferred:
Intangible assets		$ 0.7
Canopy Biosciences | Backlog
Business Acquisition [Line Items]
Amortization period for intangible assets acquired		1 year
Allocation of Consideration Transferred:
Intangible assets		$ 0.3